Southwest Synthetic Pharmaceutical Corp Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NABUMETONE USP, with a corresponding US DMF Number 18581.
Remarkably, this DMF maintains an Active status since its submission on June 24, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 08, 2014, and payment made on May 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II